Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine

Marshall J. Glesby, Richard D Moore, Richard E Chaisson

Research output: Contribution to journalArticle

Abstract

To determine the prevalence, incidence, and effects on disease progression and survival of herpes zoster in patients with advanced human immunodeficiency virus (HIV) disease, data from a multicenter observational cohort study of 1044 patients with AIDS or AIDS-related complex (ARC) and CD4 cell count ≤0.25 × 109/L treated with zidovudine were analyzed. Of 163 patients (16%) with a history of herpes zoster at enrollment, 22 (13%) had a recurrence during the 2-year follow-up. For those without prior herpes zoster, the probability of its development was 6.3% at 1 and 8.8% at 2 years. Progression to AIDS was not associated with herpes zoster. By proportional hazards analysis, an initial occurrence of herpes zoster was associated with prolonged survival independent of baseline CD4 cell count and disease stage; however, recurrence tended to be associated with death. Thus, herpes zoster is relatively common in advanced HIV infection and its initial occurrence late in disease may indicate improved prognosis.

Original languageEnglish (US)
Pages (from-to)1264-1268
Number of pages5
JournalJournal of Infectious Diseases
Volume168
Issue number5
StatePublished - Nov 1993

Fingerprint

Zidovudine
Herpes Zoster
Virus Diseases
HIV
CD4 Lymphocyte Count
Acquired Immunodeficiency Syndrome
AIDS-Related Complex
Recurrence
Survival
Observational Studies
Disease Progression
Cohort Studies
Incidence

ASJC Scopus subject areas

  • Immunology
  • Public Health, Environmental and Occupational Health

Cite this

Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. / Glesby, Marshall J.; Moore, Richard D; Chaisson, Richard E.

In: Journal of Infectious Diseases, Vol. 168, No. 5, 11.1993, p. 1264-1268.

Research output: Contribution to journalArticle

@article{f097af2a296e4e2db423874ec7b6eac0,
title = "Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine",
abstract = "To determine the prevalence, incidence, and effects on disease progression and survival of herpes zoster in patients with advanced human immunodeficiency virus (HIV) disease, data from a multicenter observational cohort study of 1044 patients with AIDS or AIDS-related complex (ARC) and CD4 cell count ≤0.25 × 109/L treated with zidovudine were analyzed. Of 163 patients (16{\%}) with a history of herpes zoster at enrollment, 22 (13{\%}) had a recurrence during the 2-year follow-up. For those without prior herpes zoster, the probability of its development was 6.3{\%} at 1 and 8.8{\%} at 2 years. Progression to AIDS was not associated with herpes zoster. By proportional hazards analysis, an initial occurrence of herpes zoster was associated with prolonged survival independent of baseline CD4 cell count and disease stage; however, recurrence tended to be associated with death. Thus, herpes zoster is relatively common in advanced HIV infection and its initial occurrence late in disease may indicate improved prognosis.",
author = "Glesby, {Marshall J.} and Moore, {Richard D} and Chaisson, {Richard E}",
year = "1993",
month = "11",
language = "English (US)",
volume = "168",
pages = "1264--1268",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine

AU - Glesby, Marshall J.

AU - Moore, Richard D

AU - Chaisson, Richard E

PY - 1993/11

Y1 - 1993/11

N2 - To determine the prevalence, incidence, and effects on disease progression and survival of herpes zoster in patients with advanced human immunodeficiency virus (HIV) disease, data from a multicenter observational cohort study of 1044 patients with AIDS or AIDS-related complex (ARC) and CD4 cell count ≤0.25 × 109/L treated with zidovudine were analyzed. Of 163 patients (16%) with a history of herpes zoster at enrollment, 22 (13%) had a recurrence during the 2-year follow-up. For those without prior herpes zoster, the probability of its development was 6.3% at 1 and 8.8% at 2 years. Progression to AIDS was not associated with herpes zoster. By proportional hazards analysis, an initial occurrence of herpes zoster was associated with prolonged survival independent of baseline CD4 cell count and disease stage; however, recurrence tended to be associated with death. Thus, herpes zoster is relatively common in advanced HIV infection and its initial occurrence late in disease may indicate improved prognosis.

AB - To determine the prevalence, incidence, and effects on disease progression and survival of herpes zoster in patients with advanced human immunodeficiency virus (HIV) disease, data from a multicenter observational cohort study of 1044 patients with AIDS or AIDS-related complex (ARC) and CD4 cell count ≤0.25 × 109/L treated with zidovudine were analyzed. Of 163 patients (16%) with a history of herpes zoster at enrollment, 22 (13%) had a recurrence during the 2-year follow-up. For those without prior herpes zoster, the probability of its development was 6.3% at 1 and 8.8% at 2 years. Progression to AIDS was not associated with herpes zoster. By proportional hazards analysis, an initial occurrence of herpes zoster was associated with prolonged survival independent of baseline CD4 cell count and disease stage; however, recurrence tended to be associated with death. Thus, herpes zoster is relatively common in advanced HIV infection and its initial occurrence late in disease may indicate improved prognosis.

UR - http://www.scopus.com/inward/record.url?scp=0027375530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027375530&partnerID=8YFLogxK

M3 - Article

C2 - 8228361

AN - SCOPUS:0027375530

VL - 168

SP - 1264

EP - 1268

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -